Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-044542

Chief Finance & Strat Officer gave up 4,406 shares (to pay taxes)

  • Chief Finance & Strat Officer acquired 16,623 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward Chief Finance & Strat Officer 2025-10-03 Option exercise +16,623 127,387 D
Stelmakh Edward Chief Finance & Strat Officer 2025-10-03 Shares withheld for taxes −4,406 $18.75 $82,613 122,981 D
Derivatives
Stelmakh Edward Chief Finance & Strat Officer 2025-10-03 Option exercise · Restricted Stock Units −16,623 0 D
Loading xslF345X05/wk-form4_1759875956.xml…